Taro Pharmaceutical Industries Ltd. TARO
$ 42.97
0.0%
Annual report 2022
added 07-25-2022
Taro Pharmaceutical Industries Ltd. Income Statement 2011-2024 | TARO
Annual Income Statement Taro Pharmaceutical Industries Ltd.
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.36 B | 1.83 B | 2.73 B | 4.19 B | 3.58 B | 4.21 B | 5.23 B | 5.26 B | 4.35 B | 2.36 B | 1.72 B | 1.23 B |
Shares |
37.6 M | 38.2 M | 38.5 M | 39 M | 40.2 M | 41.3 M | 42.8 M | 42.8 M | 44.3 M | 44.7 M | 44.6 M | 44.5 M |
Historical Prices |
36 | 48.9 | 71.5 | 67.3 | 89.4 | 85.7 | 105 | 127 | 132 | 97.5 | 49.8 | 33.2 |
Net Income |
58.3 M | -387 M | 244 M | 282 M | 211 M | 456 M | 541 M | 484 M | 360 M | 266 M | 47.3 M | 183 M |
Revenue |
561 M | 549 M | 645 M | 670 M | 662 M | 879 M | 951 M | 863 M | 759 M | 671 M | 145 M | 506 M |
Cost of Revenue |
268 M | 252 M | 245 M | 224 M | 198 M | 208 M | 170 M | 186 M | 179 M | 176 M | - | 176 M |
Gross Profit |
293 M | 297 M | 400 M | 446 M | 464 M | 672 M | 781 M | 677 M | 580 M | 495 M | 99.2 M | 330 M |
Operating Income |
63.5 M | -414 M | 247 M | 296 M | 303 M | 515 M | 614 M | 528 M | 430 M | 329 M | - | 204 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | 609 K |
EBITDA |
89.4 M | -390 M | 268 M | 315 M | 320 M | 530 M | 629 M | 543 M | 447 M | 346 M | 70.8 M | 223 M |
Operating Expenses |
230 M | 710 M | 153 M | 150 M | 160 M | 156 M | 164 M | 149 M | 150 M | 166 M | 128 M | 125 M |
General and Administrative Expenses |
57.1 M | 52.8 M | 56.8 M | 90 M | 88.2 M | 85.7 M | 92.4 M | 87.6 M | 91.7 M | 86.4 M | 23.1 M | 93.9 M |
All numbers in USD currency
Quarterly Income Statement Taro Pharmaceutical Industries Ltd.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | - | - | - | 37.9 M | - | - | - | 38.3 M | - | - | - | 38.5 M | - | - | - | 39.4 M | - | - | - | 40.5 M | - | - | - | 42.8 M | - | - | - | 42.8 M | - | - | - | 42.8 M | - | - | - | 44.8 M | - | - | - | 44.5 M | 44.5 M | - | - | 44.3 M |
Net Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 47.3 M | - | - | - | 25.7 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 145 M | - | - | - | 108 M |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 46 M | - | - | - | 44.6 M |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99.2 M | - | - | - | 63.1 M |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 66.2 M | - | - | - | 33.4 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -94 K | - | - | - | 251 K |
EBITDA |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 70.8 M | - | - | - | 38.1 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.9 M | - | - | - | 29.7 M |
General and Administrative Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.74 M | - | - | - | 22.5 M |
All numbers in USD currency